Literature DB >> 26289599

Ouabain Regulates CFTR-Mediated Anion Secretion and Na,K-ATPase Transport in ADPKD Cells.

Kyle Jansson1,2, Jessica Venugopal1,2, Gladis Sánchez1,2, Brenda S Magenheimer3,2, Gail A Reif4,2, Darren P Wallace1,4,2, James P Calvet3,2, Gustavo Blanco5,6.   

Abstract

Cyst enlargement in autosomal dominant polycystic kidney disease (ADPKD) requires the transepithelial secretion of fluid into the cyst lumen. We previously showed that physiological amounts of ouabain enhance cAMP-dependent fluid secretion and cyst growth of human ADPKD cyst epithelial cells in culture and formation of cyst-like dilations in metanephric kidneys from Pkd1 mutant mice. Here, we investigated the mechanisms by which ouabain promotes cAMP-dependent fluid secretion and cystogenesis. Ouabain (3 nM) enhanced cAMP-induced cyst-like dilations in embryonic kidneys from Pkd1 (m1Bei) mice, but had no effect on metanephroi from Pkd1 (m1Bei) mice that lack expression of the cystic fibrosis transmembrane conductance regulator (CFTR). Similarly, ouabain stimulation of cAMP-induced fluid secretion and in vitro cyst growth of ADPKD cells were abrogated by CFTR inhibition, showing that CFTR is required for ouabain effects on ADPKD fluid secretion. Moreover, ouabain directly enhanced the cAMP-dependent Cl(-) efflux mediated by CFTR in ADPKD monolayers. Ouabain increased the trafficking of CFTR to the plasma membrane and up-regulated the expression of the CFTR activator PDZK1. Finally, ouabain decreased plasma membrane expression and activity of the Na,K-ATPase in ADPKD cells. Altogether, these results show that ouabain enhances net fluid secretion and cyst formation by activating apical anion secretion via CFTR and decreasing basolateral Na(+) transport via Na,K-ATPase. These results provide new information on the mechanisms by which ouabain affects ADPKD cells and further highlight the importance of ouabain as a non-genomic stimulator of cystogenesis in ADPKD.

Entities:  

Keywords:  Cystogenesis; Fluid secretion; Polycystic kidney disease; Signaling

Mesh:

Substances:

Year:  2015        PMID: 26289599      PMCID: PMC4672947          DOI: 10.1007/s00232-015-9832-7

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  53 in total

1.  Different expression and activity of the alpha1 and alpha4 isoforms of the Na,K-ATPase during rat male germ cell ontogeny.

Authors:  K Wagoner; G Sanchez; A-N Nguyen; G C Enders; G Blanco
Journal:  Reproduction       Date:  2005-11       Impact factor: 3.906

Review 2.  Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease.

Authors:  Gustavo Blanco; Darren P Wallace
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-12

Review 3.  Molecular diagnostics for autosomal dominant polycystic kidney disease.

Authors:  Peter C Harris; Sandro Rossetti
Journal:  Nat Rev Nephrol       Date:  2010-02-23       Impact factor: 28.314

4.  Ouabain induces cell proliferation through calcium-dependent phosphorylation of Akt (protein kinase B) in opossum kidney proximal tubule cells.

Authors:  Syed J Khundmiri; Melissa A Metzler; Mohamed Ameen; Vishal Amin; Madhavi J Rane; Nicholas A Delamere
Journal:  Am J Physiol Cell Physiol       Date:  2006-06-28       Impact factor: 4.249

5.  A microplate assay measuring chloride ion channel activity.

Authors:  M R West; C R Molloy
Journal:  Anal Biochem       Date:  1996-10-01       Impact factor: 3.365

Review 6.  Signaling mechanisms that link salt retention to hypertension: endogenous ouabain, the Na(+) pump, the Na(+)/Ca(2+) exchanger and TRPC proteins.

Authors:  Mordecai P Blaustein; John M Hamlyn
Journal:  Biochim Biophys Acta       Date:  2010-03-06

7.  Chloride and fluid secretion by cultured human polycystic kidney cells.

Authors:  D P Wallace; J J Grantham; L P Sullivan
Journal:  Kidney Int       Date:  1996-10       Impact factor: 10.612

8.  Ouabain activates the Na-K-ATPase signalosome to induce autosomal dominant polycystic kidney disease cell proliferation.

Authors:  Anh-Nguyet T Nguyen; Kyle Jansson; Gladis Sánchez; Madhulika Sharma; Gail A Reif; Darren P Wallace; Gustavo Blanco
Journal:  Am J Physiol Renal Physiol       Date:  2011-06-22

Review 9.  Polycystin-1: a master regulator of intersecting cystic pathways.

Authors:  Sorin V Fedeles; Anna-Rachel Gallagher; Stefan Somlo
Journal:  Trends Mol Med       Date:  2014-01-31       Impact factor: 11.951

10.  Organ hypertrophic signaling within caveolae membrane subdomains triggered by ouabain and antagonized by PST 2238.

Authors:  Mara Ferrandi; Isabella Molinari; Paolo Barassi; Elena Minotti; Giuseppe Bianchi; Patrizia Ferrari
Journal:  J Biol Chem       Date:  2004-05-25       Impact factor: 5.157

View more
  5 in total

1.  Evidence for metabotropic function of epithelial nicotinic cholinergic receptors in rat colon.

Authors:  Lena Lottig; Sandra Bader; Marcel Jimenez; Martin Diener
Journal:  Br J Pharmacol       Date:  2019-04-09       Impact factor: 8.739

2.  Ouabain promotes partial epithelial to mesenchymal transition (EMT) changes in human autosomal dominant polycystic kidney disease (ADPKD) cells.

Authors:  Jessica Venugopal; Jeffrey McDermott; Gladis Sanchez; Madhulika Sharma; Leandro Barbosa; Gail A Reif; Darren P Wallace; Gustavo Blanco
Journal:  Exp Cell Res       Date:  2017-04-03       Impact factor: 3.905

3.  Stimulation of Na+ -K+ -pump currents by epithelial nicotinic receptors in rat colon.

Authors:  Sandra Bader; Lena Lottig; Martin Diener
Journal:  Br J Pharmacol       Date:  2017-03-23       Impact factor: 8.739

Review 4.  On the Many Actions of Ouabain: Pro-Cystogenic Effects in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Jessica Venugopal; Gustavo Blanco
Journal:  Molecules       Date:  2017-05-03       Impact factor: 4.411

5.  Ouabain-Induced Gene Expression Changes in Human iPSC-Derived Neuron Culture Expressing Dopamine and cAMP-Regulated Phosphoprotein 32 and GABA Receptors.

Authors:  Alexander V Lopachev; Maria A Lagarkova; Olga S Lebedeva; Margarita A Ezhova; Rogneda B Kazanskaya; Yulia A Timoshina; Anastasiya V Khutorova; Evgeny E Akkuratov; Tatiana N Fedorova; Raul R Gainetdinov
Journal:  Brain Sci       Date:  2021-02-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.